ArticleOncology letters2019

Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report.

Takeshi Azuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.